These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
874 related items for PubMed ID: 19602006
1. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection. Briganti A, Karakiewicz PI, Chun FK, Suardi N, Gallina A, Abdollah F, Freschi M, Doglioni C, Rigatti P, Montorsi F. Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006 [Abstract] [Full Text] [Related]
2. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. Briganti A, Capitanio U, Chun FK, Gallina A, Suardi N, Salonia A, Da Pozzo LF, Colombo R, Di Girolamo V, Bertini R, Guazzoni G, Karakiewicz PI, Montorsi F, Rigatti P. Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383 [Abstract] [Full Text] [Related]
8. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Briganti A, Chun FK, Salonia A, Zanni G, Scattoni V, Valiquette L, Rigatti P, Montorsi F, Karakiewicz PI. Eur Urol; 2006 Jun; 49(6):1019-26; discussion 1026-7. PubMed ID: 16530933 [Abstract] [Full Text] [Related]
9. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. Briganti A, Chun FK, Salonia A, Gallina A, Zanni G, Scattoni V, Valiquette L, Rigatti P, Montorsi F, Karakiewicz PI. Urology; 2007 Jan; 69(1):147-51. PubMed ID: 17270638 [Abstract] [Full Text] [Related]
10. Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin. Briganti A, Shariat SF, Chun FK, Hutterer GC, Roehrborn CG, Gallina A, Rigatti P, Valiquette L, Montorsi F, Karakiewicz PI. BJU Int; 2007 Sep; 100(3):528-32. PubMed ID: 17573893 [Abstract] [Full Text] [Related]
13. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Da Pozzo LF, Cozzarini C, Briganti A, Suardi N, Salonia A, Bertini R, Gallina A, Bianchi M, Fantini GV, Bolognesi A, Fazio F, Montorsi F, Rigatti P. Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184 [Abstract] [Full Text] [Related]
14. Predictors of Lymph Node Invasion in Patients with Clinically Localized Prostate Cancer Who Undergo Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: The Role of Obesity. Tafuri A, Rizzetto R, Amigoni N, Sebben M, Shakir A, Gozzo A, Odorizzi K, Gallina S, Bianchi A, Ornaghi P, Brunelli M, Migliorini F, Cerruto MA, Artibani W, Siracusano S, Antonelli A, Porcaro AB. Urol Int; 2021 May; 105(5-6):362-369. PubMed ID: 33059351 [Abstract] [Full Text] [Related]
15. Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium. Chun FK, Briganti A, Gallina A, Hutterer GC, Shariat SF, Antebie E, Walz J, Roehrborn CG, Salonia A, Rigatti P, Saad F, Huland H, Montorsi F, Graefen M, Karakiewicz PI. Eur Urol; 2007 Oct; 52(4):1067-74. PubMed ID: 17383807 [Abstract] [Full Text] [Related]
16. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. Cagiannos I, Karakiewicz P, Eastham JA, Ohori M, Rabbani F, Gerigk C, Reuter V, Graefen M, Hammerer PG, Erbersdobler A, Huland H, Kupelian P, Klein E, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Morash CG, Scardino PT, Kattan MW. J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779 [Abstract] [Full Text] [Related]
19. Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series. Abdollah F, Cozzarini C, Suardi N, Gallina A, Capitanio U, Bianchi M, Tutolo M, Salonia A, La Macchia M, Di Muzio N, Rigatti P, Montorsi F, Briganti A. Int J Radiat Oncol Biol Phys; 2012 Jun 01; 83(2):624-9. PubMed ID: 22099031 [Abstract] [Full Text] [Related]